Privia Health Group, Inc. (PRVA)
| Market Cap | 2.59B-17.4% |
| Revenue (ttm) | 2.36B |
| Net Income | 28.12M |
| EPS | 0.21 |
| Shares Out | 127.73M |
| PE Ratio | 96.52 |
| Forward PE | 19.07 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 152,444 |
| Open | 20.27 |
| Previous Close | 20.30 |
| Day's Range | 20.13 - 20.35 |
| 52-Week Range | 18.91 - 28.82 |
| Beta | 0.80 |
| Analysts | Strong Buy |
| Price Target | 31.47(+55.26%) |
| Earnings Date | Nov 5, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About PRVA
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$PRVA stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in PRVA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PRVA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PRVA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PRVA Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Capitated revenue | $95.15M | 43.25% |
| Shared savings | $68.92M | 31.33% |
| FFS-administrative services | $33.22M | 15.10% |
| Care management fees (PMPM) | $20.73M | 9.42% |
| Other revenue | $1.97M | 0.89% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PRVA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PRVA from public contracts
Source: USAspending.gov
PRVA Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from PRVA’s recent data — informational, not investment advice